Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
02/2000
02/29/2000US6030643 Potassium, sodium and tris oxaprozin salt pharmaceutical formulations
02/24/2000WO2000009106A2 Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
02/24/2000WO1999062504A3 Topical administration of oxazolidinones for transdermal delivery
02/24/2000CA2336154A1 Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
02/23/2000EP0980535A1 Photochromic compositions, photochromic compounds (co)polymers matrices
02/23/2000EP0980361A1 Substituted diphenyl oxazolin derivatives with insecticidal effect
02/22/2000US6028214 GABA and L-glutamic acid analogs for antiseizure treatment
02/22/2000US6028090 Adhesion receptor antagonists III
02/22/2000US6028089 Use for combating animal pests; for killing insects, arachnida and nematodes
02/17/2000WO2000008018A1 Benzothiepin derivatives, process for the preparation of the same and uses thereof
02/17/2000WO2000008002A1 SUBSTITUTED OXAZOLES AND THIAZOLES DERIVATIVES AS hPPAR GAMMA AND hPPAR ALPHA ACTIVATORS
02/17/2000WO2000007997A1 IMIDAZOLES AND RELATED COMPOUNDS AS α1A AGONISTS
02/17/2000DE19834325A1 New benzo-condensed heterocyclic compounds useful in treatment of thrombosis and prevention of vascular occlusion
02/17/2000CA2339773A1 Substituted oxazoles and thiazoles derivatives as hppar gamma and hppar alpha activators
02/17/2000CA2339662A1 Benzothiepin derivatives, their production and use
02/17/2000CA2338594A1 Imidazoles and related compounds as .alpha.1a agonists
02/16/2000EP0979077A1 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
02/16/2000CN1244862A Endothelin antagonists: N-[[2'-[[4,5-dimethyl-3-isoxazolyl) amino] sulfonyl]-4-(2-oxazolyl) [1,1'-biphenyl]-2-yl] methyl]
02/15/2000US6025378 Antiatherosclerotic action.
02/15/2000US6025376 Chiral methylphenyloxazolidinones
02/15/2000US6025375 4,5-diaryloxazole derivatives
02/15/2000US6025177 Asymmetric grignard synthesis with cyclic 1,2 aminoalcohols
02/15/2000US6025147 Inhibitors of interleukin-1 β converting enzyme
02/10/2000WO2000006577A1 OXAZOLO, THIAZOLO AND SELENAZOLO [4,5-c]-QUINOLIN-4-AMINES AND ANALOGS THEREOF
02/10/2000WO2000006556A1 Substituted oxazolines as antiproliferative agents
02/10/2000WO2000006153A1 Propenamides as ccr5 modulators
02/10/2000WO2000005956A1 Herbicidal phenoxypropionic acid n-alkyl-n-2-fluorophenyl amide compounds
02/10/2000WO1999063944A3 Novel therapeutic agents that modulate estrogen receptors
02/10/2000CA2338804A1 Propenamides as ccr5 modulators
02/09/2000EP0977745A1 Thioaryl sulfonamide hydroxamic acid compounds
02/09/2000EP0977742A1 The preparation of enantiomerically enriched oxazolones and alpha, alpha-disubstituted amino acids
02/09/2000EP0977563A1 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
02/09/2000CN1244122A Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
02/08/2000US6022976 Process for the production of 5-hydroxyoxazolidinones
02/08/2000US6022967 Heterocyclic compounds
02/03/2000WO2000005224A2 Heterocyclic derivatives and their use as integrin inhibitor
02/03/2000WO2000005223A2 Heterocyclic derivatives and their use as integrin inhibitors
02/03/2000WO2000005221A1 Substituted benzoylcyclohexandiones
02/03/2000WO2000004865A2 Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives
02/03/2000WO1999063936A3 Novel therapeutic agents that modulate endothelin receptors
02/03/2000WO1999063933A3 Multivalent agonists, partial agonists and antagonists of the gaba receptors
02/03/2000WO1999063929A3 Multibinding inhibitors of microsomal triglyceride transferase protein
02/03/2000CA2338310A1 Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives
02/03/2000CA2338304A1 Substituted benzoylcyclohexandiones
02/02/2000EP0976818A1 Use of glycin-N,N-diacetic acid derivatives as biodegradable complexing agents for alkaline earth and heavy metal ions, in compact powder-, ultra compact powder- and liquid-detergentcompositions
02/02/2000EP0976740A1 A synthesizing method for a 3-substituted-3-OXO-2-(2,4- Oxazolidinedion-3-YL)propionic acid amide compound
02/02/2000CN1243509A Endothelin intermediates by asymmetric conjugate addition reaction using a chiral additive
02/02/2000CN1048983C Preparation of new initiator of taxane derivative and its use
02/01/2000US6020497 3-substitutes isoxazolidines as chiral auxiliary agents
02/01/2000US6020496 5-alkoxy-2(3H)-oxazolone compounds and process for preparing the same
02/01/2000US6020491 Monomeric and polymeric cyclic amine and N-halamine compounds
02/01/2000CA2195064C Amino-acid amide derivatives, processes for preparing the same, agricultural or horticultural fungicides, and method for killing fungi
01/2000
01/27/2000WO2000004020A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
01/27/2000WO2000004007A1 Fluorescent dibenzazole derivatives and methods related thereto
01/27/2000WO2000004003A1 Ccr-3 receptor antagonists
01/27/2000WO2000003988A1 Novel benzoic acid derivatives and processes for the preparation thereof
01/27/2000WO2000003710A1 Oxazolidinones to treat eye infections
01/27/2000WO1999063930A3 Novel angiotensin receptor modulators and their uses
01/27/2000WO1999058477A3 N-[3-[2-[(2,3-dihydro-1h-inden-2-yl)alkylamino]-ethyl]phenyl carboxamide derivatives, preparation and therapeutic applications
01/27/2000DE19921732A1 New 2-benzoyl-1,3-cyclohexanedione derivatives useful as herbicides, especially for selective weed control in monocot crops, e.g. maize
01/27/2000CA2337377A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
01/27/2000CA2334811A1 Oxazolidinones to treat eye infections
01/26/2000EP0973742A1 Endothelin intermediates by asymmetric conjugate addition reaction using a chiral additive
01/26/2000EP0973512A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
01/26/2000EP0973392A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
01/25/2000US6017929 Cholinesterase activator
01/25/2000US6017928 Retroviral protease inhibiting compounds
01/20/2000WO2000002881A2 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein
01/20/2000WO2000002871A1 Novel angiogenesis inhibitors
01/20/2000WO1999048897B1 Synthesis of compounds and libraries of compounds
01/20/2000CA2336848A1 Novel angiogenesis inhibitors
01/19/2000EP0971895A1 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor
01/19/2000EP0971709A1 Novel compounds useful as neuro-protective agents
01/19/2000EP0672038B1 Herbicides
01/19/2000CN1242012A N-(pyridinylamino) isoindolines for treating alzheimer's and depression
01/19/2000CN1242006A Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
01/18/2000US6015827 Benzoxazole-4-carboxamides and their use in inhibiting poly (adp-ribose) polymerase activity and improving cytotoxic effectiveness of cytotoxic drugs or radiotherapy
01/18/2000US6015824 Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders
01/18/2000US6015823 4-Cyclohexylphenyl-oxazolines and their use for controlling animal pests
01/13/2000WO2000001695A1 New benzoxazoles with pde-inhibiting activity
01/13/2000WO2000001679A1 Retinoid-associated receptor regulators
01/13/2000WO1999018941A3 Ih-MODULATORS
01/13/2000CA2336894A1 New benzoxazoles with pde-inhibiting activity
01/13/2000CA2332178A1 Retinoid-associated receptor function regulating agent
01/12/2000EP0970077A1 Improved method for producing thiazolidinediones, and new thiazolidinediones
01/12/2000EP0970063A1 Process for the preparation of substituted thiazolidinedione
01/12/2000EP0970060A1 Lta 4 hydrolase inhibitors
01/12/2000EP0970059A1 Disubstituted biphenyloxazolines
01/12/2000EP0970046A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
01/12/2000EP0969829A1 Synthetic techniques and intermediates for polyhydroxy, dienyllactones and mimics thereof
01/12/2000EP0599968B1 Oxazolidinone derivatives useful as antiarrhythmic and antifibrillatory agents
01/11/2000US6013830 Chemical intermediates for oxybutynin, oxyphencyclimine, oxyphenonium bromide, oxypyrronium bromide, and oxysonium iodide, for which cyclohexylphenylglycolic acid (chpga) is of special interest; stereoselectivity
01/06/2000WO2000000477A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
01/06/2000WO2000000458A1 Substituted propionyl derivatives and intermediates thereof
01/06/2000CA2336625A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
01/05/2000EP0968198A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR INHIBITING $g(b)-AMYLOID PEPTIDE
01/05/2000EP0968179A1 N-sulphonyl and n-sulphinyl amino acid amides as microbiocides
01/05/2000EP0776884B1 Substituted amide derivative
01/05/2000EP0664792B1 Fibrinogen receptor antagonists
01/05/2000CN1240419A Aromatic amine derivatives having NOS inhibitory effect